# TAGRISSO

NDC: 0310-1350
Generic name: osimertinib
Labeler / Manufacturer: AstraZeneca Pharmaceuticals LP
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20151113

FDA application: NDA208065

## Active ingredients

- OSIMERTINIB: 80 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0310-1350"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0310-1350
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5e81b4a7-b971-45e1-9c31-29cea8c87ce7